IBDEI0IG ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8284,2)
 ;;=^5015649
 ;;^UTILITY(U,$J,358.3,8285,0)
 ;;=N31.9^^55^537^45
 ;;^UTILITY(U,$J,358.3,8285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8285,1,3,0)
 ;;=3^Neuromuscular dysfunction of bladder, unspecified
 ;;^UTILITY(U,$J,358.3,8285,1,4,0)
 ;;=4^N31.9
 ;;^UTILITY(U,$J,358.3,8285,2)
 ;;=^5015648
 ;;^UTILITY(U,$J,358.3,8286,0)
 ;;=N31.0^^55^537^63
 ;;^UTILITY(U,$J,358.3,8286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8286,1,3,0)
 ;;=3^Uninhibited neuropathic bladder, not elsewhere classified
 ;;^UTILITY(U,$J,358.3,8286,1,4,0)
 ;;=4^N31.0
 ;;^UTILITY(U,$J,358.3,8286,2)
 ;;=^5015644
 ;;^UTILITY(U,$J,358.3,8287,0)
 ;;=N31.1^^55^537^57
 ;;^UTILITY(U,$J,358.3,8287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8287,1,3,0)
 ;;=3^Reflex neuropathic bladder, not elsewhere classified
 ;;^UTILITY(U,$J,358.3,8287,1,4,0)
 ;;=4^N31.1
 ;;^UTILITY(U,$J,358.3,8287,2)
 ;;=^5015645
 ;;^UTILITY(U,$J,358.3,8288,0)
 ;;=N36.44^^55^537^43
 ;;^UTILITY(U,$J,358.3,8288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8288,1,3,0)
 ;;=3^Muscular disorders of urethra
 ;;^UTILITY(U,$J,358.3,8288,1,4,0)
 ;;=4^N36.44
 ;;^UTILITY(U,$J,358.3,8288,2)
 ;;=^5015676
 ;;^UTILITY(U,$J,358.3,8289,0)
 ;;=N34.1^^55^537^49
 ;;^UTILITY(U,$J,358.3,8289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8289,1,3,0)
 ;;=3^Nonspecific urethritis
 ;;^UTILITY(U,$J,358.3,8289,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,8289,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,8290,0)
 ;;=N39.0^^55^537^69
 ;;^UTILITY(U,$J,358.3,8290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8290,1,3,0)
 ;;=3^Urinary tract infection, site not specified
 ;;^UTILITY(U,$J,358.3,8290,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,8290,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,8291,0)
 ;;=R31.9^^55^537^23
 ;;^UTILITY(U,$J,358.3,8291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8291,1,3,0)
 ;;=3^Hematuria, unspecified
 ;;^UTILITY(U,$J,358.3,8291,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,8291,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,8292,0)
 ;;=R31.0^^55^537^22
 ;;^UTILITY(U,$J,358.3,8292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8292,1,3,0)
 ;;=3^Gross hematuria
 ;;^UTILITY(U,$J,358.3,8292,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,8292,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,8293,0)
 ;;=R31.2^^55^537^42
 ;;^UTILITY(U,$J,358.3,8293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8293,1,3,0)
 ;;=3^Microscopic hematuria NEC
 ;;^UTILITY(U,$J,358.3,8293,1,4,0)
 ;;=4^R31.2
 ;;^UTILITY(U,$J,358.3,8293,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,8294,0)
 ;;=N40.0^^55^537^17
 ;;^UTILITY(U,$J,358.3,8294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8294,1,3,0)
 ;;=3^Enlarged prostate without lower urinary tract symptoms
 ;;^UTILITY(U,$J,358.3,8294,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,8294,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,8295,0)
 ;;=N40.1^^55^537^16
 ;;^UTILITY(U,$J,358.3,8295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8295,1,3,0)
 ;;=3^Enlarged prostate with lower urinary tract symptoms
 ;;^UTILITY(U,$J,358.3,8295,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,8295,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,8296,0)
 ;;=N40.2^^55^537^47
 ;;^UTILITY(U,$J,358.3,8296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8296,1,3,0)
 ;;=3^Nodular prostate without lower urinary tract symptoms
 ;;^UTILITY(U,$J,358.3,8296,1,4,0)
 ;;=4^N40.2
 ;;^UTILITY(U,$J,358.3,8296,2)
 ;;=^5015691
 ;;^UTILITY(U,$J,358.3,8297,0)
 ;;=N41.0^^55^537^4
 ;;^UTILITY(U,$J,358.3,8297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8297,1,3,0)
 ;;=3^Acute prostatitis
 ;;^UTILITY(U,$J,358.3,8297,1,4,0)
 ;;=4^N41.0
 ;;^UTILITY(U,$J,358.3,8297,2)
 ;;=^259106
